EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work ...

In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann ...

Mast cell platform can expand to carry other payloads, such as molecules, viruses, proteins and drug-loaded nanoparticles.

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.

Researchers are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus.

A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric ...

Using human intestinal organoids, scientists uncovered a previously unknown immune function of M cells. By presenting gluten ...

Rodríguez-Otero is medical coordinator of the Central Unit for Clinical Trials; associate clinical professor, preclinical and hematology seminars; and deputy director of the expert degree in ...

BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...

"When you are prescribed antibiotics, take them as prescribed and DON'T keep some extra so you can 'use them next time you’re ...

Scientists have utilised revolutionary DNA base editing to treat previously incurable T-cell acute lymphoblastic leukaemia.

Longtime WCVB and ABC News medical editor Dr. Timothy Johnson, 89, revealed a prostate cancer diagnosis after a PSA test and ...